FAQ

NSC 329680

Known as: NSC-329680 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2006
02419882006

Related topics

Related topics

1 relation

Broader (1)

hepsulfam

Related mentions per year

Related mentions per year

1987-2010
1980199020002010
NSC 329680
hepsulfam

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Hepsulfam, a New Antileukemic Agent, in the L1210 Cell Line Comparison of the Mechanism of Action of Busulfan with
1,7-1 Irpiatirti ¡ol d¡sull'amati-(hepsulfam, NSC 329680) is a new antileukemic agent with close structural similarity to… (More)
  • figure 4
  • figure 5
  • figure 2
  • figure 3
Is this relevant?
2006
2006
Comparison of the Mechanism of Action of Busulfan with Hepsulfam, a New Antileukemic Agent, in the LI 210 Cell Line1
1,7-1 Irpiatirti ¡ol d¡sull'amati-(hepsulfam, NSC 329680) is a new antileukemic agent with close structural similarity to… (More)
  • figure 4
  • figure 5
  • figure 2
  • figure 3
Is this relevant?
1995
1995
Hepsulfam distribution in blood, plasma and cerebrospinal fluid of baboons
The alkylating agent Hepsulfam (Sulfamic acid 1,7-heptanediyl ester, NSC 329680) was developed as a more hydrophilic analog of… (More)
  • table 1
Is this relevant?
1993
1993
In vitro cytotoxicity of hepsulfam against human tumor cell lines and primary human tumor colony forming units.
Hepsulfam (sulfamic acid 1,7-heptanediyl ester, NSC 329680) is an alkylating agent currently in Phase I clinical trials… (More)
Is this relevant?
1992
1992
Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance.
Hepsulfam (NSC 329680, 1,7-heptanediol disulfamate) is an alkylating agent that showed excellent activity against mouse and human… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1992
1992
Preclinical activity of hepsulfam and busulfan in solid human tumor xenografts and human bone marrow.
Hepsulfam (1,7-heptanediol disulfamate, NSC 329680) is a new antineoplastic alkanesulfonate agent which has demonstrated a… (More)
Is this relevant?
1991
1991
Phase I and pharmacokinetic study of hepsulfam (NSC 329680).
Hepsulfam (NSC 329680), a bifunctional alkylating agent structurally related to busulfan, has entered clinical trial based on its… (More)
  • table 3
  • table 5
  • figure 2
  • figure 3
Is this relevant?
1990
1990
Mechanisms of toxicity of hepsulfam in human tumor cell lines.
1,7-Heptanediol disulfamate (hepsulfam, NSC 329680) is a new anti-cancer agent which is currently undergoing phase I clinical… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
1989
1989
Comparison of the mechanism of action of busulfan with hepsulfam, a new antileukemic agent, in the L1210 cell line.
1,7-Heptanediol disulfamate (hepsulfam, NSC 329680) is a new antileukemic agent with close structural similarity to busulfan. The… (More)
Is this relevant?
1988
1988
Gas chromatographic assay for the new antitumor agent sulfamic acid diester (NSC 329680) and its stability in buffer, blood and plasma.
A sensitive gas chromatographic assay with electron-capture detection has been developed for sulfamic acid diester (sulfamic acid… (More)
Is this relevant?